AGP Executive Report
Last update: 12 hours agoSickle Cell Care in Africa: A Senegalese company, Teranga Pharma, says it has started producing a generic version of hydroxyurea—the WHO-recommended treatment that can cut painful crises, hospital stays, transfusions, and early death—aiming to reduce the heavy burden of imported medicines across West Africa. TB Vaccine Update: A phase 3 trial in sub-Saharan Africa found a new TB vaccine candidate (VPM1002) did not meet the standard set by BCG for preventing TB infection in newborns, underscoring the need for better options. Arms Control & Health Security: At the Arms Trade Treaty conference in Geneva (Aug 24–28), a Gabonese diplomat urged African states to sign, ratify, and fully embed the treaty into national law to curb illicit small arms and light weapons. Health Research Openness: The University of Miami’s gift of its 1994 ibogaine Investigational New Drug application to the U.S. government is being framed as a step toward open science standards. Quiet, Wellness-Adjacent Travel: Gabon ranks among the world’s quietest countries in a Noise-Free Nations Index, with Bhutan taking top spot—an angle for readers thinking about calmer, nature-focused trips.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
